For UC, RCC, EC/GEJ/G, ICIs combination with chemotherapy therapy, anti-PD-1or anti-PD-L1, first or subsequent line of treatment, the efficacy of ICIs was not significant different. This evidence concerns the gene CD274 and renal cell carcinoma.